NCT04380545 2026-03-06Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar CancerM.D. Anderson Cancer CenterPhase 1/2 Recruiting15 enrolled
NCT07214298 2026-02-06Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal AdenocarcinomaRoswell Park Cancer InstitutePhase 1/2 Recruiting35 enrolled